Compounded Tirzepatide · Dual GLP-1/GIP Weight Loss
Dual GLP-1/GIP Receptor Agonist — Physician-Supervised · Chatsworth & Santa Barbara, CA
Naya Wellness offers a clinician-guided compounded tirzepatide program — a dual GLP-1/GIP agonist that activates two metabolic pathways simultaneously for faster, more dramatic fat loss than semaglutide alone. Average weight loss of 20–22% of body weight. Available in-person at our Chatsworth and Santa Barbara clinics, or via telehealth statewide.
Tirzepatide is a dual GLP-1/GIP receptor agonist — a breakthrough medication that activates TWO metabolic hormones simultaneously. Unlike semaglutide, which targets only GLP-1, tirzepatide engages both GLP-1 and GIP receptors, resulting in significantly more powerful appetite suppression, metabolic activation, and fat loss.
At Naya Wellness, we prescribe compounded tirzepatide from a state-licensed 503A pharmacy, paired with B6 or Vitamin B12 to reduce nausea and support energy. This allows for personalized dosing and ongoing clinical adjustments tailored to your specific needs.
Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. Our compounded version offers the same proven dual-action mechanism at flexible dosing, typically at a lower cost than brand-name alternatives.
Results vary by individual. All programs are physician-supervised. Compounded tirzepatide is not FDA-approved. Dispensed from state-licensed 503A compounding pharmacies. After your consultation and prescription, compounded tirzepatide is shipped directly from a state-licensed 503A pharmacy to your home in California (shipping and handling included), and follow-up check-ins are handled via telehealth.
The Program
Getting started is straightforward. Our clinical team guides you from evaluation to results with ongoing support at every step.
Meet with our physician or nurse practitioner — in-person at Chatsworth or Santa Barbara, or via telehealth — to review your health history, weight loss goals, and determine your eligibility for compounded tirzepatide.
Your clinician creates a titrated dosing schedule starting at a low dose, increasing gradually over weeks to minimize side effects and maximize fat loss. Tirzepatide is paired with B6 or B12 for optimal tolerance.
Monthly check-ins — in-person or virtual — to review your progress, adjust dosing, and provide nutrition and lifestyle coaching. Our team is available throughout your entire program.
Comparison
Both are powerful GLP-1 medications, but tirzepatide's dual-action mechanism delivers faster, stronger results for most patients.
Why Tirzepatide
Tirzepatide offers a medically proven path to faster, more dramatic weight loss — especially for patients who need rapid progress.
20–22% average weight loss — significantly higher than semaglutide's 15–20%, delivering faster progress toward your goals.
GLP-1 + GIP activation simultaneously — a breakthrough approach that is significantly more powerful than single-receptor medications.
Dramatically reduced hunger signals and portion sizes — making it easier to stick with healthy eating without constant cravings.
Beyond weight loss, tirzepatide improves insulin sensitivity, reduces A1C, lowers blood glucose, and enhances cardiovascular health.
A single weekly subcutaneous injection — self-administered at home — eliminates the burden of daily pills or complex dosing schedules.
Every tirzepatide program is managed by a licensed clinician. Personalized dosing, direct access, and accountability at Chatsworth or Santa Barbara.
Locations
In-person consultations and ongoing care at both California clinics — or telehealth for patients statewide.
Our flagship Chatsworth clinic serves the San Fernando Valley and greater Los Angeles area with in-person tirzepatide consultations, dosing management, and ongoing physician-supervised care.
Our Santa Barbara clinic offers tirzepatide programs for the Central Coast and South Coast regions. In-person visits and telehealth consultations available for California patients.
Eligibility
A clinical evaluation will confirm your eligibility. Most adults who meet one or more of the following criteria are good candidates.
"The tirzepatide program at Naya completely changed my relationship with food. I lost 32 lbs in 5 months and my energy is through the roof."
— Naya Wellness Patient
Get Started Today
Schedule a consultation at Chatsworth or Santa Barbara — in-person or via telehealth — and find out how compounded tirzepatide can help you lose weight faster and more dramatically.
Chatsworth: (818) 341-8888 · Santa Barbara: (805) 308-5444 · Telehealth available statewide
FAQ
Compounded tirzepatide is the identical active ingredient found in Mounjaro® (approved for type 2 diabetes) and Zepbound® (approved for weight loss). At Naya Wellness, we source it from a state-licensed 503A compounding pharmacy at flexible, personalized doses — typically offering better pricing than brand-name versions while maintaining identical efficacy. All programs are physician-supervised and paired with B6 or B12 for optimal tolerance and results.
Tirzepatide activates both GLP-1 and GIP receptors simultaneously — a dual-action mechanism that is significantly more potent than semaglutide's single GLP-1 action. This results in faster weight loss (20–22% vs. 15–20%), stronger appetite suppression, and greater metabolic improvements. Tirzepatide is ideal for patients who need more rapid progress or have not responded well to semaglutide alone.
Clinical studies demonstrate an average weight loss of 20–22% of total body weight with tirzepatide over 6–12 months of physician-supervised treatment — notably higher than semaglutide's 15–20%. Individual results vary based on starting weight, lifestyle, nutrition, and program adherence. At Naya Wellness, our clinicians monitor your progress and adjust dosing to optimize your outcomes.
The most common side effects are mild nausea, reduced appetite, and occasional gastrointestinal discomfort — particularly when starting or increasing the dose. These typically resolve within a few weeks. Because tirzepatide is more potent than semaglutide, side effects may be slightly more pronounced initially; however, Naya's gradual titration protocol and B6/B12 supplementation significantly minimize discomfort while maximizing results.
Yes, clinical data shows tirzepatide typically produces faster, stronger weight loss (20–22% vs. 15–20%), greater appetite suppression, and superior metabolic improvements due to its dual GLP-1/GIP mechanism. However, semaglutide remains an excellent option for patients seeking steady, predictable progress. Our physicians will evaluate your health profile and recommend the best option for your individual needs.
Tirzepatide is appropriate for adults with a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. It is ideal for patients who have struggled to lose weight with diet and exercise alone — particularly those who want faster, more significant results or who have not responded adequately to semaglutide. A clinical consultation will confirm your eligibility.
Yes. Many patients transition from semaglutide to tirzepatide to achieve faster, more dramatic results. Naya's physicians will review your previous progress, current weight, health goals, and adjust your tirzepatide dosing protocol accordingly. A transition consultation — in-person or via telehealth — ensures a safe, optimized switch.
Book a consultation online at visit.nayawell.com or call Chatsworth (818) 341-8888 or Santa Barbara (805) 308-5444. Our clinical team will review your medical history, assess your eligibility, and create a personalized tirzepatide dosing plan. Consultations are available in-person at either location or via telehealth for California patients. Most patients can begin treatment on the same day as their initial consultation.
Explore More
Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces appetite and improves metabolic function for medically supervised weight loss.
Tirzepatide activates two hormone receptors rather than one, and clinical data shows greater average weight loss with tirzepatide in head-to-head studies.
Tirzepatide is self-injected once weekly as a subcutaneous injection in the abdomen, thigh, or upper arm.
Adults with a BMI of 27 or above with a weight-related health condition, or a BMI of 30 or above, may qualify after a medical evaluation at Naya Wellness.
Naya Wellness now offers Tirzepatide at our Santa Barbara clinic — serving Montecito, Goleta & the South Coast.
View Tirzepatide in Santa Barbara →